Although there is a common clinical assumption that bipolar disorder with psychotic features reflects greater severity than bipolar disorder without psychosis, the existing empirical literature is mixed. This study investigated the phenomenology of psychosis as well as demographic, clinical, functional, and neuropsychological features in a large, cross-sectional sample of participants with bipolar disorder divided by history of psychosis.
more "severe" form of illness than BP without psychosis, and may resemble the clinical and functional deterioration commonly seen in primary psychotic disorders. This notion is supported by the Diagnostic and Statistical Manual of Mental Disorders, 5, 6 where the presence of psychosis automatically changes an otherwise hypomanic episode to a manic episode (and a corresponding bipolar I disorder diagnosis).
Overlapping genetic findings between BP and schizophrenia have also contributed to this assumption, 7, 8 although low odds ratios reported limit the conclusiveness of these results. The empirical literature in this area is mixed. Relatively few studies have examined demographic, clinical, and neuropsychological differences among individuals diagnosed with affective-only BP (BP-A) and psychotic BP (BP-P), with few conclusive findings. The question of whether the presence of psychosis in BP truly represents a more "severe" subtype of illness, as is currently assumed, has important nosological and treatment implications. This study investigated the phenomenology of psychotic features as well as clinical, functional, and neuropsychological differences between BP-A and BP-P participants in a large cross-sectional sample.
Regarding demographic, functional, and clinical differences, a 2010 meta-analysis revealed that, compared with BP-A, BP-P participants had more inpatient hospitalizations, younger age of onset, and fewer years of education, although there were no significant differences for age, gender, or duration of illness. 9 A later study with 199 BP participants found that BP-P participants had a shorter duration of illness, fewer episodes of elevated mood, fewer current depressive symptoms, and lower current functioning scores than BP-A participants.
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Other studies have failed to find any differences between BP-A and BP-P participants. For example, Keck et al. 11 enrolled 352 participants with bipolar I disorder-the largest published study before this present study-and explored a range of variables including age, gender, ethnicity, education, psychosocial support, income, vocational status, illness characteristics like the presence of mixed episodes or rapid cycling, age of treatment initiation, history of suicide attempts, and presence of comorbid disorders, and found no significant differences between BP-P and BP-A groups. They did find that BP-P participants were less likely to have a first-degree relative diagnosed with BP.
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As for neuropsychological functioning, several studies have compared neuropsychological performance between BP-A and BP-P par- 
| MATERIALS AND METHODS

| Participants
Participants 
| Procedures
| Measures
The DIGS is a clinical interview designed to assess major mood and psychotic disorders and related conditions; it also includes a detailed assessment of the course and chronology of symptoms and therefore yields an abundance of clinical information. 14 Specific clinical variables used in the analyses were derived from the DIGS and included history of mixed episodes, history of suicidality, substance abuse chronicity, functional impact of illness, first-degree relative with BP, chronicity of affective disorder, and presence of rapid cycling. Ratings that were classified as "uncertain" were recoded as missing data. In addition to the DIGS, participants completed numerous neuropsychological measures; these variables were subjected to standard data reduction techniques using confirmatory factor analysis and described elsewhere.
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The resulting factors included auditory memory, visual memory, fine motor skill, emotion processing, and four domains of executive functioning: verbal fluency and processing speed, processing speed with interference resolution, conceptual reasoning and set-shifting, and inhibitory control. These neuropsychological domains and their constituent measures are summarized in Figure 1 .
| Analyses
Participants with BP and no history of psychosis (BP-A) were com- son purposes, we also performed the same analyses using the sample including these two participants, and the results were identical and thus are not reported here.
Continuous clinical variables included age of onset, duration of illness (years), and medication load (described below). Ordinal variables (categories with increasing level of severity) were analyzed identically to continuous variables and included history of mixed episodes, history of suicidal thoughts or behavior, history of substance abuse, and functional impact of illness (a global rating of the degree to which psychiatric illness has led to disability or inability to live independently).
Total medication load was assessed using a protocol commonly used in the literature and fully described in a previous report; briefly, it involved coding psychiatric medications based on standardized dose equivalents and summing them to create a composite measure.
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Medications were also coded and analyzed between groups according to type, including mood stabilizer, antipsychotic, antidepressant, and benzodiazepine. Categorical variables included first-degree relative with BP, chronicity of affective disorder, and presence of rapid cycling.
Category labels for each clinical variable can be found in Figure 2 .
To characterize the strength of the evidence in favor of the null hypotheses, Bayes factors were calculated for each of the demographic, clinical, and neuropsychological comparisons using the R package "BayesFactor". 17 The Bayesian approach considers data using a ratio that contrasts the likelihood of the data fitting under the alternative hypothesis with the likelihood of fitting under the null hypothesis; this ratio is expressed as the Bayes factor. 18 The distinct advantage of this approach over (or in addition to) traditional frequentist hypothesis testing is that it provides an estimate of the amount of evidence present in the data, facilitating the interpretation of P-values that may be approaching the selected cutoff for statistical significance. Figure 3 details the range and type of psychotic symptoms reported by participants with a confirmed history of psychosis (n=213; 53%).
| RESULTS
| Sample characteristics
| Phenomenology of psychosis
The majority of BP-P participants reported experiencing delusional ideation, with nearly half experiencing grandiose delusions. Less than half of BP-P participants experienced hallucinations in any modality.
Relatively few BP-P participants endorsed traditional "first-rank" hallucinations of running commentary or two or more voices conversing.
| Comparisons among BP-A and BP-P participants
Demographically, there were no significant differences between groups on age, education, gender, age of onset, or medication load (all P>.152; Table 1 ). Examining classes of medications, BP-P participants were more likely to be prescribed mood-stabilizing or antipsychotic medication, although Bayes factors indicate only anecdotal evidence for higher rates; there were no differences between groups on prescription of antidepressant or benzodiazepine medication (Table 1 ).
In terms of clinical and functional variables, there were no sig- Regarding neuropsychological functioning, there were no significant differences between BP-A and BP-P participants in any of the eight neuropsychological domains (all P>.059; Figure 1 ). Bayes factors ranged from 0.14 to 0.68, indicating anecdotal to substantial evidence for the null hypothesis ( Figure 1 ).
| DISCUSSION
This study examined the phenomenology of psychosis in BP as well as demographic, clinical, and neuropsychological differences between people diagnosed with BP with and without a history of psychosis.
F I G U R E 1
Neuropsychological domain z-scores with standard error bars, t statistics, and Bayes factors for group comparisons. These z-scores were calculated using the mean and standard deviation of the healthy control (HC) participants enrolled in this study. The y-axis on the Bayes factor graph is on a log-scale. ; fine motor dexterity=Purdue Pegboard
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; emotion processing=Facial Emotion Perception Test 24, 25 ; verbal fluency and processing speed=Controlled Oral Word Association Test letter and animal fluency, 26 The prevalence of psychosis in this sample (53%) is similar to other published reports. 4, 11 The type and content of psychosis endorsed in this sample are also consistent with the BP literature, in that a large number of participants endorsed grandiose ideation and relatively few endorsed Schneiderian first-rank symptoms that are traditionally more evident in schizophrenia. 4 For the most part, psychosis in BP also tends to be mood congruent and of briefer duration than in schizophrenia. Such a qualitative difference in psychosis between BP and schizophrenia suggests that, experientially, psychotic symptoms may manifest differently in the context of a mood disorder vs a primary psychotic disorder; that is, the experience of psychosis as part of broader psychopathology may not improve diagnostic specificity, although the content may offer a clue as to the primary etiology and in turn inform appropriate treatment planning. Clinicians may find this helpful when conducting cross-sectional diagnostic interviews and attempting to achieve the difficult task of distinguishing between BP and schizophrenia-spectrum disorder.
In general, and somewhat contrary to expectation, our analyses largely failed to find significant clinical or functional differences between the groups. Consistent with Aminoff et al., 10 in the full sample BP-P participants were found to have shorter duration of illness than BP-A participants. The difference of 22 vs 25 years is not likely to be clinically significant, and because participants did not differ on current age or age of onset, it could simply reflect a sampling issue (i.e., individuals experiencing psychosis may have come to the attention of referral sources more swiftly than their counterparts without psychosis). The results also indicate that BP-A participants had more chronic affective symptoms and rapid cycling, consistent with a subtype of patients with primary mood burden (e.g., chronic or persistent depression rather than brief, episodic psychosis). The lack of significant differences in numerous demographic or illness burden variables is consistent with other studies finding minimal differences between BP-A and BP-P participants.
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In terms of neuropsychological functioning, surprisingly BP-A and BP-P participants did not differ on measures of auditory and visual memory, fine motor dexterity, emotion processing, or executive functioning (verbal fluency and processing speed, processing speed with interference resolution, conceptual reasoning and setshifting, and inhibitory control). It is not the case that this sample was unusually neuropsychologically intact, as the BP participants performed more poorly than healthy controls in all measured domains (z-scores<0). So, although BP participants with and without psychosis were more cognitively impaired relative to control participants, they did not significantly differ from each other. That is to say, in this sample the presence of psychosis was not associated F I G U R E 3 Psychosis phenomenology among bipolar disorder with a history of psychosis (BP-P) participants (n=213)
T A B L E 1 Demographic and clinical characteristics and comparisons between affective-only bipolar disorder (BP-A) and bipolar disorder with a history of psychosis (BP-P) participants Longitudinal collection of clinical data (as is being done in the parent study) will be helpful to decrease reliance on retrospective report. 
CONFLICTS OF INTEREST
